ARI-1778

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameARI-1778

Drug Alias Nameapo-A1 agonist (Kos Pharmaceuticals)apolipoprotein-A1 agonist (Kos Pharmaceuticals)apolipoprotein-A1 mimetic peptide (Abbott)reverse-D-4Fapolipoprotein-A1 agonist (Abbott) +[10]

ClassificationSmall molecules > Peptidomimetic

Mechanisms of ActionHDL cholesterol modulatorsApolipoprotein A-I modulators

TargetsApolipoprotein A-I

Therapy Area/IndicationsAtherosclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesArisaph Pharmaceuticals Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAbbott Laboratories Kos Pharmaceuticals Inc Arisaph Pharmaceuticals Inc

Active IndicationsN/A

Inactive IndicationsAtherosclerosis

Other Information

ATC CodeN/A